Waldencast plc (NASDAQ:WALD) Given Consensus Recommendation of “Moderate Buy” by Analysts

Waldencast plc (NASDAQ:WALD) has earned a consensus rating of “Moderate Buy” from the six ratings firms that are presently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating on the company. The average 12 month target price among brokers that have updated their coverage on the stock in the last year is $5.40.

A number of equities research analysts recently weighed in on the company. Alliance Global Partners initiated coverage on Waldencast in a research report on Tuesday, April 22nd. They set a “buy” rating and a $5.00 target price on the stock. Industrial Alliance Securities set a $5.00 price objective on Waldencast in a research report on Tuesday. Telsey Advisory Group set a $5.00 target price on Waldencast in a research report on Thursday, March 20th. Finally, DA Davidson reissued a “buy” rating and issued a $7.50 price target on shares of Waldencast in a report on Wednesday, March 19th.

Waldencast Stock Down 4.6 %

NASDAQ WALD opened at $2.69 on Tuesday. The company’s fifty day moving average is $2.94 and its two-hundred day moving average is $3.26. Waldencast has a 52-week low of $2.31 and a 52-week high of $5.46. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.78 and a current ratio of 1.47.

Institutional Trading of Waldencast

A number of large investors have recently bought and sold shares of the stock. Barclays PLC lifted its holdings in shares of Waldencast by 301.4% during the third quarter. Barclays PLC now owns 32,436 shares of the company’s stock valued at $117,000 after acquiring an additional 24,355 shares during the period. JPMorgan Chase & Co. increased its position in shares of Waldencast by 52.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 43,250 shares of the company’s stock worth $157,000 after purchasing an additional 14,803 shares in the last quarter. SG Americas Securities LLC bought a new position in Waldencast during the 4th quarter valued at about $42,000. Catalina Capital Group LLC boosted its position in Waldencast by 69.9% in the fourth quarter. Catalina Capital Group LLC now owns 27,102 shares of the company’s stock valued at $109,000 after buying an additional 11,154 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. grew its stake in Waldencast by 16.4% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 64,895 shares of the company’s stock worth $261,000 after buying an additional 9,130 shares during the last quarter. 41.97% of the stock is currently owned by institutional investors.

About Waldencast

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.